Result of WRAP Retail Offer

Renalytix is pleased to announce, further to its announcement of 3 September 2026, the completion of the WRAP Retail Offer at an issue price of £0.06 per Ordinary Share (the "Placing Price"). Pursuant to the WRAP Retail Offer, the Company has raised aggregate gross proceeds of £380,142.12, in addition to the £10.1 million gross proceeds raised through the Placing and Subscription, which was previously announced at 7.00 a.m. on 3 September 2026. Accordingly, the Company proposes to allot and issue a total of 6,335,707 Retail Offer Shares, subject to the passing of certain resolutions at the General Meeting.

In addition, and further to the Company's announcement dated 3 September 2026, VenHedge Capital Partners, LP ("VenHedge") has amended its total subscription amount to US$2.25 million (being £1,661,988) as one of its LPs, Feynman Point Asset Management Master Fund Ltd ("Feynman"), has decided to participate in the Subscription at a total amount of $500,000 (being £369,331) directly rather than via VenHedge. VenHedge have entered into an updated subscription agreement to reflect a total subscription of US$2.25 million (being £1,661,988), whilst Feynman have provided the Company with a subscription agreement to reflect a total subscription of $500,000 (being £369,331). The total subscription amount from VenHedge and its associated parties remains US$2.75 million (being £2,031,319).

In total, the Placing, the Subscription and the WRAP Retail Offer have raised gross proceeds of approximately £10.5 million for the Company, of which £3.9 million is conditional upon the passing of certain resolutions at the General Meeting.

For the avoidance of doubt, the WRAP Retail Offer is not part of the Placing. The issue of the Retail Offer Shares (and the Second Tranche Placing Shares and the Subscription Shares) is conditional upon, inter alia:

It is anticipated that First Admission will become effective and that dealings in the First Tranche Placing Shares and the Conversion Shares will commence on AIM at 8.00 a.m. today. It is anticipated that Second Admission is expected to become effective with dealings in the Retail Offer Shares, the Second Tranche Placing Shares and the Subscription Shares will commence on AIM at 8.00 a.m. on 29 September 2026 (subject to the passing of the resolutions at the General Meeting).

Second Tranche of the Fundraise

The second tranche of the Fundraise, which will be subject to shareholder approval at the General Meeting, will consist of the issue of 7,500,000 Second Tranche Placing Shares, 52,792,950 Subscription Shares and 6,335,707 Retail Offer Shares, totalling 66,628,657 Ordinary Shares.

Close of Capital Access Window and Resumption of Trading

Following completion of the WRAP Retail Offer, the Company confirms that the Capital Access Window, which commenced at 7.45 am on 1 September 2026, has now closed.

Accordingly, the Company's existing Ordinary Shares are expected to resume trading on AIM at 7.30 am today alongside the admission of the 166,811,996 First Tranche Shares, comprising 109,082,255 First Tranche Placing Shares and 57,729,741 Conversion Shares.

Terms used but not defined in this announcement have the same meaning as set out in the Company's 'Result of Fundraise' announcement released at 7.00 a.m. on 3 September 2026.